Catalyst Pharmaceuticals (CPRX) Depreciation and Depletion (2010 - 2026)
Catalyst Pharmaceuticals (CPRX) reported Depreciation and Depletion of $70000.0 for Q1 2026, down 39.13% on a YoY basis from $115000.0 in Q1 2025, and down 2.78% quarter-over-quarter from $72000.0 in Q4 2025.
Catalyst Pharmaceuticals (CPRX) Depreciation and Depletion (2010 - 2026) Analysis & Trends
Catalyst Pharmaceuticals has reported Depreciation and Depletion for 17 years, with the latest figure at $70000.0 in Q1 2026.
- For the quarter ending Q1 2026, Depreciation and Depletion fell 39.13% year-over-year to $70000.0; the trailing twelve-month figure through Mar 2026 stood at $330000.0 (down 22.54% YoY), and the FY2025 full-year result was $375000.0, down 5.54% from the prior year.
- Depreciation and Depletion for Q1 2026 stood at $70000.0, down from $72000.0 in the prior quarter.
- The five-year high for Depreciation and Depletion was $116000.0 in Q2 2025, with the low at $34000.0 in Q1 2022.
- Historically, Depreciation and Depletion has averaged $76411.8 across 5 years, with a median of $81000.0 in 2023.
- Annual changes were most pronounced in 2022 — Depreciation and Depletion slumped 64.95% — and 2023, when it jumped 140.0%.
- Catalyst Pharmaceuticals' Depreciation and Depletion stood at $35000.0 in 2022, then jumped by 140.0% to $84000.0 in 2023, then jumped by 35.71% to $114000.0 in 2024, then sank by 36.84% to $72000.0 in 2025, then dropped by 2.78% to $70000.0 in 2026.
- The last three Depreciation and Depletion figures came in at $70000.0 (Q1 2026), $72000.0 (Q4 2025), and $72000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1,395.22 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1,330.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Catalyst Pharmaceuticals | 3.84 Bn | 3.08 Bn | 134.92 Mn | 70,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 70,000.00 |
| Mar 31, 2026 | 70,000.00 |
| Dec 31, 2025 | 72,000.00 |
| Dec 31, 2025 | 72,000.00 |
| Sep 30, 2025 | 72,000.00 |
| Sep 30, 2025 | 72,000.00 |
| Jun 30, 2025 | 116,000.00 |
| Jun 30, 2025 | 116,000.00 |
| Mar 31, 2025 | 115,000.00 |
| Mar 31, 2025 | 115,000.00 |
| Dec 31, 2024 | 114,000.00 |
| Dec 31, 2024 | 114,000.00 |
| Sep 30, 2024 | 106,000.00 |
| Sep 30, 2024 | 106,000.00 |
| Jun 30, 2024 | 91,000.00 |
| Jun 30, 2024 | 91,000.00 |
| Mar 31, 2024 | 86,000.00 |
| Mar 31, 2024 | 86,000.00 |
| Dec 31, 2023 | 84,000.00 |
| Dec 31, 2023 | 84,000.00 |